Julie R Park

Julie R Park

UNVERIFIED PROFILE

Are you Julie R Park?   Register this Author

Register author
Julie R Park

Julie R Park

Publications by authors named "Julie R Park"

Are you Julie R Park?   Register this Author

84Publications

2641Reads

24Profile Views

The challenge of defining "ultra-high-risk" neuroblastoma.

Pediatr Blood Cancer 2019 Apr 26;66(4):e27556. Epub 2018 Nov 26.

Hospital for Sick Children and University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27556
Publisher Site
http://dx.doi.org/10.1002/pbc.27556DOI Listing
April 2019

Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion.

Biol Blood Marrow Transplant 2019 02 10;25(2):223-232. Epub 2018 Oct 10.

Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington; Fred Hutchinson Cancer Research Center, Seattle, Washington; Seattle Children's Hospital, Department of Pediatrics, University of Washington, Seattle, Washington; Department of Bioengineering, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183061
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.10.004DOI Listing
February 2019

Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.

Pediatr Blood Cancer 2019 01 27;66(1):e27421. Epub 2018 Aug 27.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27421DOI Listing
January 2019

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.

JCO Clin Cancer Inform 2018 12;2:1-15

Arlene Naranjo, University of Florida, Gainesville, FL; Meredith S. Irwin, Hospital for Sick Children, Toronto, ON, Canada; Michael D. Hogarty, University of Pennsylvania, Philadelphia, PA; Susan L. Cohn, The University of Chicago, Chicago, IL; Julie R. Park, University of Washington, Seattle, WA; and Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421832PMC
December 2018

Neuroblastoma and Histone Demethylation.

N Engl J Med 2018 10;379(15):1476-1477

From the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston (S.G.D.); and the Department of Pediatrics, Seattle Children's Hospital and University of Washington School of Medicine, Seattle (J.R.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcibr1806782DOI Listing
October 2018

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.

J Glob Oncol 2018 09;4:1-12

Mahmoud M. Elzembely, Paul A. Carpenter, and K. Scott Baker, Fred Hutchinson Cancer Research Center; Julie R. Park, Navin Pinto, Paul A. Carpenter, and K. Scott Baker, University of Washington; Julie R. Park, Navin Pinto, Paul A. Carpenter, and K. Scott Baker, Seattle Children's Hospital, Seattle WA; Mahmoud M. Elzembely, Khaled F. Riad, and Heba A. Sayed, South Egypt Cancer Institute, Assiut University, Assiut; Alaa El-Haddad, El-Sheikh Zayed Specialized Hospital; Alaa El-Haddad, 57357 Children's Cancer Hospital; and Alaa El-Haddad, Cairo University, Cairo, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223425PMC
September 2018

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.

Transfusion 2018 06 13;58(6):1414-1420. Epub 2018 Mar 13.

Center for Clinical and Translational Research, Seattle Children's Hospital and Research Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.14569
Publisher Site
http://dx.doi.org/10.1111/trf.14569DOI Listing
June 2018

Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.

Pediatr Blood Cancer 2017 Nov 10;64(11). Epub 2017 May 10.

Department of Laboratories, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.26613
Publisher Site
http://dx.doi.org/10.1002/pbc.26613DOI Listing
November 2017

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Eur J Cancer 2017 02 26;72:177-185. Epub 2016 Dec 26.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258837PMC
February 2017

Neuroblastoma: A Tough Nut to Crack.

Am Soc Clin Oncol Educ Book 2016 ;35:e548-57

From the Center for Medical Genetics Ghent, Cancer Research Institute Ghent, Ghent, Belgium; Seattle Children's Hospital, Seattle, WA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA; University of Chicago Comer Children's Hospital, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159169DOI Listing
January 2017

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma.

J Clin Oncol 2017 Jan 21;35(2):208-216. Epub 2016 Nov 21.

Daniel von Allmen, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Andrew M. Davidoff, St Jude Children's Research Hospital, Memphis, TN; Wendy B. London, Boston Children's Hospital; Wendy B. London and Daphne A. Haas-Kogan, Dana-Farber Cancer Institute; Harvard Medical School; and Daphne A. Haas-Kogan, Brigham and Women's Hospital, Boston, MA; Collin Van Ryn, University of Florida Health Science Center, Gainesville, FL; Susan G. Kreissman, Duke University School of Medicine, Durham, NC; Geetika Khanna, Washington University School of Medicine, St Louis, MO; Nancy Rosen, Quality Assurance Review Committee, Providence, RI; Julie R. Park, University of Washington School of Medicine; Seattle Children's Hospital, Seattle, WA; Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center; Weill Cornell Medical School, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2642DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455676PMC
January 2017

When Life Expectancy is Not Short Enough: A Perspective on the National Institute for Health and Care Excellence (NICE) Preliminary Guidance for Dinutuximab.

Pediatr Blood Cancer 2016 Jun 6;63(6):962-3. Epub 2016 Jan 6.

Formerly, Division of Clinical Studies, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25891DOI Listing
June 2016

¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications.

Semin Nucl Med 2016 May;46(3):184-202

Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2016.02.002DOI Listing
May 2016

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).

Pediatr Blood Cancer 2016 Mar 27;63(3):436-42. Epub 2015 Oct 27.

Department of Pediatrics, UCSF School of Medicine and UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25816DOI Listing
March 2016

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.

J Clin Oncol 2016 Mar 11;34(7):740-6. Epub 2016 Jan 11.

Rochelle Bagatell, Lisa J. States, and Alexandra Miller, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA; Arlene Naranjo and Collin Van Ryn, University of Florida, Gainesville, FL; Chaim Kirby and Sam L. Volchenboum, University of Chicago, Chicago, IL; Karen A. Lyons, Yesenia Rojas, and Jed Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Julie R. Park, Seattle Children's Hospital and University of Washington, Seattle, WA; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, London, United Kingdom; Thorsten Simon and Barbara Krug, University of Cologne Medical School, Cologne; Dietrich von Schweinitz and Birgit Kammer, Dr von Hauner Children's Hospital and University of Munich, Munich, Germany; Sabine Sarnacki, Hopital Necker-Enfants Malades and Paris Descartes University; Dominique Valteau-Couanet, Institut Gustave Roussy, Universite Paris Sud, Paris, France; and Claudio Granata and Luca Pio, Istituto Giannina Gaslini, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.2042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872026PMC
March 2016

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

J Immunother 2015 Sep;38(7):299-305

*Department of Pediatric Hematology-Oncology, Children's National Medical Center, George Washington University School of Medicine and Public Health, Washington, DC †Clinical Investigations Branch, Cancer Therapy Evaluation Program, NCI, Bethesda ¶¶Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ‡Keck School of Medicine, University of Southern California ¶Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles §Children's Oncology Group, Arcadia ‡‡Department of Pediatrics, City of Hope National Medical Center, Duarte, CA ∥Department of Biostatistics and Bioinformatics, Emory University ∥∥Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA #Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN **Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA ††Pediatric Hematology-Oncology, C.S. Mott Children's Hospital, Ann Arbor, MI §§Division of Pediatrics, Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536569PMC
September 2015

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

J Clin Oncol 2015 Sep 24;33(27):3008-17. Epub 2015 Aug 24.

Navin R. Pinto, Mark A. Applebaum, Samuel L. Volchenboum, and Susan L. Cohn, Comer Children's Hospital, University of Chicago, Chicago, IL; Katherine K. Matthay, University of California San Francisco (UCSF) Benioff Children's Hospital, UCSF School of Medicine, San Francisco, CA; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Peter F. Ambros, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Saga Medical Center Koseikan, Saga, Japan; Frank Berthold, Children's Hospital, University of Cologne, Koln, Germany; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; Julie R. Park, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; and Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3008.full.pdf
Web Search
http://200.40.135.66:90/toc/0873/2015/0873-20150920-27-07.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.4648
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.4648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567703PMC
September 2015

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.

Pediatr Dev Pathol 2014 Nov-Dec;17(6):441-9. Epub 2014 Sep 10.

1 Department of Pathology & Laboratory Medicine, Children's Hospital Los Angeles, and University of Southern California Keck School of Medicine, 4650 Sunset Boulevard, MS #43, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2350/14-06-1505-OA.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340697PMC
March 2015

Neuroblastoma: paradigm for precision medicine.

Pediatr Clin North Am 2015 Feb;62(1):225-56

Division of Hematology-Oncology, Seattle Children's Hospital, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, 4800 Sandpoint Way NE, Seattle, WA 98105, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313955140019
Publisher Site
http://dx.doi.org/10.1016/j.pcl.2014.09.015DOI Listing
February 2015

Reply to N.-K.V. Cheung et al.

J Clin Oncol 2014 Dec 17;32(36):4174-5. Epub 2014 Nov 17.

University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.7006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142206PMC
December 2014

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

Pediatr Blood Cancer 2014 Nov 7;61(11):1932-9. Epub 2014 Jul 7.

Department of Hematology/Oncology, Children's National Medical Center, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25134DOI Listing
November 2014

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Pediatr Blood Cancer 2013 Jun 19;60(6):985-93. Epub 2012 Dec 19.

Seattle Children's Hospital, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA 98106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24433DOI Listing
June 2013

About the benefits of immunotherapy for high-risk neuroblastoma.

J Clin Oncol 2013 Feb 7;31(5):649-50. Epub 2013 Jan 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.4080DOI Listing
February 2013

Functional genomics identifies therapeutic targets for MYC-driven cancer.

Proc Natl Acad Sci U S A 2012 Jun 23;109(24):9545-50. Epub 2012 May 23.

Department of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1121119109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386069PMC
June 2012

Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients.

J Pediatric Infect Dis Soc 2012 Jun 3;1(2):103-11. Epub 2012 May 3.

Fred Hutchinson Cancer Research Center, Seattle, Washington Johns Hopkins School of Medicine Sidney Kimmel Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jpids/pis044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656552PMC
June 2012

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Cancer Chemother Pharmacol 2011 Oct 22;68(4):1057-65. Epub 2011 Feb 22.

Department of Pediatrics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1581-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238911PMC
October 2011

Neuroblastoma: biology, prognosis, and treatment.

Hematol Oncol Clin North Am 2010 Feb;24(1):65-86

Division of Hematology and Oncology, University of Washington School of Medicine and Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105-0371, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S088985880900206
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2009.11.011DOI Listing
February 2010

High-risk neuroblastoma: a therapy in evolution.

Pediatr Hematol Oncol 2009 Nov;26(8):539-48

Seattle Children's Hospital and University of Washington, Department of Pediatrics, Seattle, Washington 98105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880010903121173DOI Listing
November 2009

Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group.

J Clin Pharmacol 2009 Jan 16;49(1):88-102. Epub 2008 Oct 16.

Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195-7630, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270008325928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652687PMC
January 2009

Influenza-associated morbidity in children with cancer.

Pediatr Blood Cancer 2008 May;50(5):983-7

Department of Pediatrics, University of Washington and Children's Hospital & Regional Medical Center, Seattle, Washington 98105, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.21472
Publisher Site
http://dx.doi.org/10.1002/pbc.21472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511372PMC
May 2008

Neuroblastoma: biology, prognosis, and treatment.

Pediatr Clin North Am 2008 Feb;55(1):97-120, x

Division of Hematology and Oncology, University of Washington School of Medicine and Children's Hospital and Regional Medical Center, Seattle, WA 98105-0371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcl.2007.10.014DOI Listing
February 2008

Influenza-associated morbidity in children with cancer.

Pediatr Blood Cancer 2008 May;50(5):983-7

Department of Pediatrics, University of Washington and Children's Hospital & Regional Medical Center, Seattle, Washington 98105, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.21472
Publisher Site
http://dx.doi.org/10.1002/pbc.21472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511372PMC
May 2008

Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.

Cancer 2004 Mar;100(6):1268-75

Department of Pediatric Hematology/Oncology, Children's Hospital and Regional Medical Center, Seattle, Washington 98105-5371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20091DOI Listing
March 2004

Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.

J Pediatr Hematol Oncol 2003 Apr;25(4):286-91

Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105-0371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200304000-00004DOI Listing
April 2003

Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.

Med Pediatr Oncol 2003 Feb;40(2):93-8

Pediatric Hematology/Oncology, Children's Hospital and Regional Medical Center, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mpo.10208DOI Listing
February 2003

Clinical utility of bronchoalveolar lavage in pediatric cancer patients.

Med Pediatr Oncol 2002 Sep;39(3):175-80

Department of Pediatrics, Division of Pediatric Hematology/Oncology, Children's Hospital and Regional Medical Center, University of Washington Medical School, Seattle, Washington 98105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mpo.10130DOI Listing
September 2002